Spots Global Cancer Trial Database for high grade serous adenocarcinoma of ovary

Every month we try and update this database with for high grade serous adenocarcinoma of ovary cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi	NCT06161272	Ovarian Cancer High Grade Sero... Primary Periton... Fallopian Tube ...	Fluzoparib Fluzoparib+Apat...	18 Years - 75 Years	Guangxi Medical University
A Study of Sovilnesib in Subjects With Ovarian Cancer	NCT06084416	High Grade Sero... Fallopian Tube ... Primary Periton... Chromosomal Ins...	Sovilnesib	18 Years -	Volastra Therapeutics, Inc.
First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer	NCT06063070	Ovarian Cancer High Grade Sero... High Grade Endo... Primary Periton... Fallopian-tube ...	Fluzoparib Caps... Bevacizumab	18 Years -	Sun Yat-sen University
Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors	NCT05858736	Melanoma Non Small Cell ... Head and Neck S... High Grade Sero... Primary Periton... Fallopian Tube ... Endometrial Can... Cervical Cancer Renal Cell Carc... Bladder Cancer Esophageal Canc... Gastric Cancer Gastroesophagea... Colorectal Canc... Anal Cancer Hepatocellular ... Bile Duct Cance...	AI-061	18 Years -	OncoC4, Inc.
Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi	NCT06161272	Ovarian Cancer High Grade Sero... Primary Periton... Fallopian Tube ...	Fluzoparib Fluzoparib+Apat...	18 Years - 75 Years	Guangxi Medical University
Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors	NCT05858736	Melanoma Non Small Cell ... Head and Neck S... High Grade Sero... Primary Periton... Fallopian Tube ... Endometrial Can... Cervical Cancer Renal Cell Carc... Bladder Cancer Esophageal Canc... Gastric Cancer Gastroesophagea... Colorectal Canc... Anal Cancer Hepatocellular ... Bile Duct Cance...	AI-061	18 Years -	OncoC4, Inc.
A Study of Sovilnesib in Subjects With Ovarian Cancer	NCT06084416	High Grade Sero... Fallopian Tube ... Primary Periton... Chromosomal Ins...	Sovilnesib	18 Years -	Volastra Therapeutics, Inc.
ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer	NCT05446298	Ovarian Cancer High Grade Sero... Primary Periton... Fallopian Tube ...	ONC-392 Pembrolizumab	18 Years -	OncoC4, Inc.
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer	NCT05902988	Advanced Solid ... High Grade Sero... Squamous Non-sm... Triple Negative... Gastric Adenoca... Colorectal Aden... Esophageal Squa... Esophageal Aden... Gastroesophagea... Transitional Ce... Head and Neck S... Ovarian Carcino... Uterine Carcino... Uterine Serous ... Endometrium Can... Chromosomal Ins...	VLS-1488	18 Years -	Volastra Therapeutics, Inc.
First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer	NCT06063070	Ovarian Cancer High Grade Sero... High Grade Endo... Primary Periton... Fallopian-tube ...	Fluzoparib Caps... Bevacizumab	18 Years -	Sun Yat-sen University

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: